Region: Global
Category: Pharmaceuticals

Global Pharmaceuticals

(21,765 reports matching your criteria)
  • Artificial Limbs

    ... CAGR of 4.6% over the analysis period 2024-2030. Upper Extremity Prosthetics, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$925.8 Million by the end of the ... Read More

  • Attapulgite

    ... 6.9% over the analysis period 2024-2030. Colloidal grade Attapulgite, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$320.0 Million by the end of the analysis period. ... Read More

  • Biochemical Reagents

    ... CAGR of 8.7% over the analysis period 2024-2030. PCR Reagent Kits, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$6.3 Billion by the end of the ... Read More

  • Biotechnology

    ... 8.5% over the analysis period 2024-2030. DNA Sequencing Technology, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$33.5 Billion by the end of the analysis period. ... Read More

  • Blood Transfusion Diagnostics

    ... at a CAGR of 4.7% over the analysis period 2024-2030. Blood Transfusion Diagnostic Instruments, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.7 Billion by the ... Read More

  • Diabetic Shoes

    ... CAGR of 8.1% over the analysis period 2024-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$10.6 Billion by the end of the ... Read More

  • Endometrial Ablation Devices

    ... at a CAGR of 5.6% over the analysis period 2024-2030. Radiofrequency Ablation, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$628.5 Million by the end of ... Read More

  • Fragment-based Drug Discovery

    ... at a CAGR of 8.8% over the analysis period 2024-2030. Fragment Screening Technology, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$1.1 Billion by the end ... Read More

  • LED Video Walls

    ... at a CAGR of 6.9% over the analysis period 2024-2030. Indoor Deployment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.0 Billion by the end of ... Read More

  • Nail Care

    ... CAGR of 2.6% over the analysis period 2024-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$8.3 Billion by the end of the analysis ... Read More

  • Vitreous Tamponades

    ... CAGR of 3.0% over the analysis period 2024-2030. Gaseous Tamponades, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$50.9 Million by the end of the analysis ... Read More

  • Sodium Bromide

    ... CAGR of 6.2% over the analysis period 2024-2030. Powdered Sodium Bromide, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.7 Billion by the end of the ... Read More

  • Rapid Antigen Detection Tests

    ... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.4% CAGR The Rapid Antigen Detection Tests market ... Read More

  • Neurology Devices

    ... CAGR of 5.9% over the analysis period 2024-2030. Cerebrospinal Fluid Management, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$7.1 Billion by the end of the ... Read More

  • Biologics

    ... 8.2% over the analysis period 2024-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis period. ... Read More

  • Biopharmaceutical Logistics

    ... CAGR of 4.8% over the analysis period 2024-2030. Cold Chain Logistics, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$37.9 Billion by the end of the ... Read More

  • IoT in Intelligent Transportation System

    ... Billion by 2030, growing at a CAGR of 20.0% over the analysis period 2024-2030. IoT Hardware, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$282.3 Billion ... Read More

  • Office Administrative Services

    ... at a CAGR of 7.9% over the analysis period 2024-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$62.1 Billion by the end ... Read More

  • Ophthalmic Ultrasound Systems

    ... at a CAGR of 3.9% over the analysis period 2024-2030. Portable Systems, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of ... Read More

  • Polycaprolactone

    ... 8.3% over the analysis period 2024-2030. Coating & Thermoplastic Polyurethane (TPU) Application, one of the segments analyzed in the report, is expected to record a 8.7% CAGR and reach US$141.2 Million by the end of ... Read More

  • Radiofrequency Ablation Devices for Pain Management

    ... reach US$1.4 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Disposable Products, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More

  • Thoracic Drainage Devices

    ... at a CAGR of 4.6% over the analysis period 2024-2030. Thoracic Surgery & Pulmonology, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$528.6 Million by the ... Read More

  • Weight Loss Supplements

    ... at a CAGR of 15.1% over the analysis period 2024-2030. Vitamins & Minerals Ingredient, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$79.9 Billion by the ... Read More

  • Continuous Glucose Monitoring Systems

    ... 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Sensors Component, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$5.4 Billion by the ... Read More

  • Rheumatoid Arthritis Therapeutics

    ... at a CAGR of 4.1% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$28.0 Billion by the end of the ... Read More

Cookie Settings